Cleared Traditional

K781693 - COLLAGENREAGENT HORM

K781693 is the FDA 510(k) clearance for COLLAGENREAGENT HORM by Hormon-Chemie Munchem Gmch. It is a Class 2 Hematology device (product code JOZ) cleared through the Traditional 510(k) pathway after a 64-day FDA review.

K781693 · Hormon-Chemie Munchem Gmch · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1978
Decision
64d
Days
Class 2
Risk

K781693 is an FDA 510(k) clearance for the COLLAGENREAGENT HORM. Classified as System, Automated Platelet Aggregation (product code JOZ), Class II - Special Controls.

Submitted by Hormon-Chemie Munchem Gmch (Walker, US). The FDA issued a Cleared decision on December 7, 1978 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5700 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hormon-Chemie Munchem Gmch devices

Submission Details

510(k) Number K781693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 04, 1978
Decision Date December 07, 1978
Days to Decision 64 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 113d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JOZ System, Automated Platelet Aggregation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JOZ System, Automated Platelet Aggregation

All 15
Devices cleared under the same product code (JOZ) and FDA review panel - the closest regulatory comparables to K781693.
PLATELET AGGREGATION REAGENTS
K800146 · Pacific Hemostasis · Feb 1980
ELVI 840 AGGREGOMETER
K791577 · Volu Sol Medical Industries · Sep 1979
BETA/PAK
K790769 · Bio/Data Corp. · May 1979
SOLUBLE COLLAGEN
K780285 · General Diagnostics · Mar 1978
PLATELET AGGREGATING REAGENTS
K780047 · Dade, Baxter Travenol Diagnostics, Inc. · Mar 1978
AGGRECETIN
K760893 · Bio/Data Corp. · Jan 1977